Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 36 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean menHutchison, A.; Luscombe-Marsh, N.; Saies, A.; Little, T.; Standfield, S.; Horowitz, M.; Feinle-Bisset, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.
2008Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population studyQuan, C.; Talley, N.; Jones, M.; Howell, S.; Horowitz, M.
2013Prognosis of diabetic gastroparesisa 25-year evaluationChang, J.; Rayner, C.; Jones, K.; Horowitz, M.
2004Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesisRusso, A.; Stevens, J.; Giles, N.; Krause, G.; O'Donovan, D.; Horowitz, M.; Jones, K.
2016Small intestinal glucose delivery affects the lowering of blood glucose by acute vildagliptin in type 2 diabetesWu, T.; Zhang, X.; Trahair, L.; Bound, M.; Little, T.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2018Impact of gastric emptying and small intestinal transit on blood glucose, intestinal hormones, glucose absorption in the morbidly obeseNguyen, Q.; Debreceni, T.; Burgess, J.; Bellon, M.; Wishart, J.; Standfield, S.; Malbert, C.-H.; Horowitz, M.
2012Comparative effects on glucose absorption of intragastric and post-pyloric nutrient delivery in the critically illDi Bartolomeo, A.; Chapman, M.; Zaknic, A.; Summers, M.; Jones, K.; Nguyen, Q.; Rayner, C.; Horowitz, M.; Deane, A.
2011Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetesDeane, A.; Summers, M.; Zaknic, A.; Chapman, M.; Fraser, R.; Di Bartolomeo, A.; Wishart, J.; Horowitz, M.